Difference between revisions of "Team:Paris Bettencourt"

Line 22: Line 22:
 
             <a href='https://2018.igem.org/Team:Paris_Bettencourt/Human_Practices'>
 
             <a href='https://2018.igem.org/Team:Paris_Bettencourt/Human_Practices'>
 
                 <div class='large-block-content'>
 
                 <div class='large-block-content'>
                      
+
                     <img src="https://static.igem.org/mediawiki/2018/d/d6/T--Paris_Bettencourt--Public_Engagement.png">
 
                 </div>
 
                 </div>
 
                 <div>Human Practices I </div>
 
                 <div>Human Practices I </div>
Line 89: Line 89:
 
             <a href='https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement'>
 
             <a href='https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement'>
 
                 <div class='large-block-content'>
 
                 <div class='large-block-content'>
                   
+
                  <img src="https://static.igem.org/mediawiki/2018/3/36/T--Paris_Bettencourt--VRPublic_Engagement.png">
 
                 </div>
 
                 </div>
 
                 <div>Human Practices II (Public Engagement)</div>
 
                 <div>Human Practices II (Public Engagement)</div>

Revision as of 23:58, 16 October 2018

Protein scaffolds for star-shaped antimicrobial peptides

Antibiotic overuse in livestock industry is one of the major drivers to the antibiotic resistance evolution; motivating calls to reduce, replace, and re-think the antibiotic usage in animals. Antimicrobial peptides (AMPs) are a promising alternative to conventional antibiotics. Recently, a class of chemically-synthesized, star-shaped AMPs has been shown to exhibit broad-spectrum antimicrobial activity while maintaining biocompatibility with mammalian cells. In this project, we combinatorially fused a set of known AMPs to structurally diverse, self-assembling protein cores to produce star-shaped complexes. Over 200 fusions were designed and expressed in a cell-free system, then screened for activity, biocompatibility, and membrane selectivity. In addition, we selected 4 AMPs for rational mutagenesis (~12000 variants), and a subset of fusions for molecular dynamic modeling, to identify features of surface charge and star geometry that impact AMP performance. Overall, we aim to create a novel class of selective, non-toxic AMPs which are biologically-produced.

Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
paris-bettencourt-2018@cri-paris.org